NLS Pfizer

In the end of November, Pfizer acquired Allergan for more than $150 billion, a deal which will create the world’s biggest drug maker. The deal, the largest ever in the healthcare sector, involves Pfizer paying with 11.3 of its shares for each Allergan share. There will also be a small cash component, accounting for less […]

Pfizer has acquired Allergan for more than $150 billion, a deal that will create the world’s biggest drug maker. The deal, the largest ever in the healthcare sector and involves Pfizer paying with 11.3 of its shares for each Allergan share. There will also be a small cash component, accounting for less than 10 percent of the […]

The Swedish MedTech company AMRA has entered into an international collaboration with Pfizer. The companies will investigate the relationship between fat and muscle distribution in the body and metabolic health, including risk factors for conditions such as obesity and diabetes. The collaboration will assess fat and muscle measurements from magnetic resonance images in up to 7,000 […]

At the end of this year Karo Bio will transfer the responsibility of the Rorgamma project to their development parter Pfizer, according to the company’s interim report for the third quarter. The rorgamma project aim to develop treatments for auto immune diseases.

Pfizer is to continue buying back stock, with the board authorizing a new $11 billion share repurchase plan, deflating expectations that it will make a new bid for AstraZeneca. Shares in AstraZeneca fell 1.2 percent by 0800 GMT on Friday following the news. Pfizer is in the middle of a strategic transformation, and has split […]

As the new head of Pfizer’s Swedish organization, Malin Parkler’s plan is to take past professional experience, multiple perspectives and the strength of collaborative leadership to lead the company forward in the fluctuating world of pharmaceuticals. Malin Parkler assumed the post as Country Manager of Pfizer Sweden this spring, taking over after Edward Lysen, in […]